ストックスクリーナーアプリを入手
194.79
0.74%
1.07
前日終値:
$193.72
開ける：
$197.47
24時間の取引高:
223.24K
Relative Volume:
0.05
時価総額：
$138.12B
収益：
$24.78B
当期純損益:
$3.68B
株価収益率:
37.65
EPS:
5.1743
ネットキャッシュフロー:
$5.29B
1週間 パフォーマンス:
+1.00%
1か月 パフォーマンス:
+10.81%
6か月 パフォーマンス:
-15.30%
1年 パフォーマンス:
-3.63%
1日の値動き範囲:
$194.47
$197.47
1週間の範囲:
$188.99
$197.47
52週間の値動き範囲:
$160.93
$242.80
Danaher Corp Stock (DHR) Company Profile
名前
Danaher Corp
セクター
電話
(202) 828-0850
住所
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, NTRA, A
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
195.15 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
TMO
Thermo Fisher Scientific Inc
|
522.55 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
IDXX
Idexx Laboratories Inc
|
540.83 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
275.49 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
133.39 | 37.52B | 7.23B | 1.41B | 1.09B | 4.979 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Goldman | Buy |
| 2025-12-02 | 開始されました | Morgan Stanley | Overweight |
| 2025-10-08 | ダウングレード | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2025-03-21 | アップグレード | Goldman | Neutral → Buy |
| 2025-03-14 | アップグレード | Stifel | Hold → Buy |
| 2025-02-03 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-12-19 | 開始されました | Guggenheim | Buy |
| 2024-12-13 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-10-31 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Equal Weight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-17 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2023-12-18 | 開始されました | HSBC Securities | Hold |
| 2023-12-13 | 再開されました | Wolfe Research | Peer Perform |
| 2023-12-07 | ダウングレード | Goldman | Buy → Neutral |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-05-01 | 開始されました | SVB Securities | Outperform |
| 2023-04-26 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-04-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-10-24 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-08-17 | 再開されました | Bernstein | Outperform |
| 2022-07-20 | 開始されました | UBS | Buy |
| 2022-06-01 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | 開始されました | Bernstein | Outperform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-10 | 繰り返されました | BofA Securities | Buy |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-23 | 繰り返されました | Goldman | Buy |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-04-07 | 再開されました | Robert W. Baird | Outperform |
| 2021-03-03 | 再開されました | Barclays | Overweight |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-25 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | 繰り返されました | Needham | Buy |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 再開されました | Stifel | Hold |
| 2019-10-28 | 繰り返されました | Needham | Buy |
| 2019-10-14 | 再開されました | Credit Suisse | Outperform |
| 2019-07-19 | 繰り返されました | Needham | Buy |
| 2019-06-11 | 開始されました | Piper Jaffray | Neutral |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-04-17 | 繰り返されました | Needham | Buy |
| 2019-02-28 | 繰り返されました | Needham | Buy |
| 2019-02-25 | アップグレード | Janney | Neutral → Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-04-20 | 繰り返されました | Stifel | Buy |
すべてを表示
Danaher Corp (DHR) 最新ニュース
Danaher Corp. focuses on diversified science tools as investors weigh long term growth - AD HOC NEWS
Danaher Corp adjusts guidance after Masimo deal. Analysts highlight cautious upside for the stock - AD HOC NEWS
Spatial Genomics and Transcriptomics Market Size to Reach USD 1.90 Billion by 2035, Growing at a 12.23% CAGR | SNS Insider - GlobeNewswire Inc.
DHRDanaher Corp Latest SEC Filings - Finviz
Deals tracker: Select Medical Holdings acquisition moves forward - Modern Healthcare
Danaher Corp. stock underperforms Monday when compared to competitors - MarketWatch
$1M Danaher grant targets Ebola outbreak in Congo, Uganda - Stock Titan
Danaher (DHR) Completes $9.9B Acquisition of Masimo Corporation - Insider Monkey
Is Danaher (DHR) One of the Best Non-Tech Stocks to Buy According to Analysts? - Insider Monkey
Danaher schedules Q2 earnings call, analysts reassess the shares - Ad-hoc-news.de
Danaher schedules Q2 earnings call, shares steady in S&P 500 - Ad-hoc-news.de
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Danaher boosts product portfolio with the acquisition of Masimo - MSN
Danaher clears new AI milestone with Masimo, shares react on NYSE - Ad-hoc-news.de
Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh - TradingView
Danaher Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
DHR Forecast — Price Target — Prediction for 2027 - TradingView
Danaher (DHR) Stock Weighs Mixed Valuation Signals After Recent Price Rebound - Yahoo Finance
Why Danaher (DHR) Stock Rose Today - Quiver Quantitative
Danaher clears FDA hurdle with Masimo, shares extend rebound on NYSE - Ad-hoc-news.de
Danaher (DHR) Crossed Above the 20-Day Moving Average: What That Means for Investors - Yahoo Finance
Why Is (NYSE:DHR) Back in Focus Following AI Monitoring Approval? - Kalkine Media
Danaher $172.5 Million Securities Class Action Settlement - Claim Depot
Is Danaher (DHR) Using Masimo’s New FDA-Cleared AI Tool To Redefine Its Medtech Edge? - Yahoo Finance
A Look at Danaher Corp (DHR) After 5.5% Gain -- GF Value $236.97 vs Price $188.87 - GuruFocus
Danaher Corp Stock (DHR) Moved Up by 4.91% on Jun 24: What Investors Need To Know - TradingKey
HSBC Cuts PT on Danaher Corporation (DHR) – Here’s Why - Insider Monkey
How FDA Clearance of AI Opioid-Respiratory Monitoring Could Shape Danaher’s (DHR) Clinical Data Advantage - simplywall.st
Danaher achieves FDA clearance for Masimo feature, shares steady on NYSE - Ad-hoc-news.de
Danaher Corp (DHR) Institutional Confidence - TradingKey
Danaher plans July 21 earnings call, slide deck at 6 a.m. ET - Stock Titan
Danaher Finalizes $9.9B Purchase of Masimo - Orange County Business Journal
Danaher (DHR) Achieves FDA Clearance for Wearable Monitoring Tec - GuruFocus
Danaher Schedules Second Quarter 2026 Earnings Conference Call - Yahoo Finance
Danaher Stockweekly outlook with earnings and events ahead - Ad-hoc-news.de
Medtech business update: Spectrum Vascular acquires Piccolo Medical, Danaher acquires Masimo - Today's Medical Developments
From bench chaos to calm order, Cytiva ÄKTA pure quietly cleans up protein prep - AD HOC NEWS
Lodi's largest private employer expands with fifth building - The Business Journals
Danaher Corp (DHR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Danaher Corp (DHR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Danaher Corp (DHR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Danaher Corp (DHR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Danaher Corp. stock outperforms competitors despite losses on the day - MarketWatch
Danaher Corp (DHR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Danaher Corp (DHR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Danaher Corp (DHR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IDBS and Alchemi partner to accelerate biopharma regulatory filings with compliant AI agents - PR Newswire
Danaher’s Cepheid Ebola Tests Highlight Diagnostics Role In Global Crises - Yahoo! Finance Canada
Masimo CEO stepping down following acquisition by Danaher - Modern Healthcare
Danaher Corporation’s (DHR) Recovery Fell Short of Investor Expectations - Yahoo Finance
Danaher Corp (DHR) 財務データ
収益
当期純利益
現金流量
EPS
1.54%
0.08%
大文字化:
|
ボリューム (24 時間):